about the company.inception in 2010, Company has consistently been at the forefront of innovation in the realms of biological reagents and proteomics. Our commitment to pioneering technologies is driving advancements in the study of protein post-translational modification (PTM) and epigenetics, effectively meeting the critical needs in these specialized fields. Our integrated platform combines exclusive PTM reagents, IVD raw materials, advanced mass spectr
about the company.inception in 2010, Company has consistently been at the forefront of innovation in the realms of biological reagents and proteomics. Our commitment to pioneering technologies is driving advancements in the study of protein post-translational modification (PTM) and epigenetics, effectively meeting the critical needs in these specialized fields. Our integrated platform combines exclusive PTM reagents, IVD raw materials, advanced mass spectr